GNE Officer D&I Spotlight (Nov)

Embracing Different Perspectives

Allen Napetian, VP of Site Services

In Allen Napetian’s 2024 D&I Officer Action Plan, he focuses on integrating diverse perspectives to tackle challenges and drive innovative solutions. Allen frequently discusses the importance of varied viewpoints in town halls and one-on-one conversations to bring awareness to his diversity and inclusion efforts.

WATCH

Watch

READ

In 2023, Neal encountered obstacles along the way, he remained adaptable and flexible in his D&I initiatives. Realizing the need to extend beyond Genentech for their summer internships, he reached out to the General Counsels of Roche Dia, FMI, Flatiron, and Spark.

READ

Encouraging Retention Across Roche’s Legal Councils

Neal Dahiya, Vice President - Litigation

These conversations sparked the idea of developing a broader US summer program aimed at nurturing talented diverse law students. This shift in perspective reinforced the significance of lateral thinking and incorporating peer affiliates into programs where it is appropriate. Neal believes in the power of collaboration and aims to explore partnerships with other Roche affiliates, especially in areas where they may benefit from Genentech's resources in the realm of D&I. Furthermore, Neal actively prioritizes and proactively reaches out to support diverse voices, both within and outside of Genentech. He engages in regular and ad hoc meetings, serving as a mentor and a valuable resource. By fostering these connections, Neal contributes to a more inclusive and supportive environment, enabling individuals to thrive and achieve their full potential. Neal's ongoing commitment to D&I is not only evident in his actions but also in his ability to inspire others. His dedication to fostering diverse talent, encouraging personal growth, and forging partnerships across the organization exemplify his leadership and the positive impact he has on the communities and employees involved in advancing D&I efforts at Genentech.

Key D&I ContributorsJayson Johnson

Key D&I ContributorsLavender Whitaker and the entire Site Services People Forum team

In Allen Napetian’s 2024 D&I Officer Action Plan, he focuses on integrating diverse perspectives to tackle challenges and drive innovative solutions. Allen frequently discusses the importance of varied viewpoints in town halls and one-on-one conversations to bring awareness to his diversity and inclusion efforts. By recognizing and valuing who is present and who is not, Allen emphasizes that diversity and inclusion strategies are straightforward yet powerful. Watch his video to learn more about how Allen's actions promote a more inclusive and innovative work environment.

To lay the groundwork for their efforts, the SKY-15 team conducted a thorough review of the underlying epidemiology and evidence base for racial differences in early non-small cell lung cancer (NSCLC). During the protocol development phase, the team examined all inclusion criteria for the study. They made a conscious effort to remove criteria that had traditionally prevented full representation in trials. For instance, the SKY-15 trial now allows HIV- and HBV-positive patients whose diseases are controlled to participate. They have pioneered a new way of working with the USMA team and US CCO, implementing a coordinated and high-touch approach to interactions with the AIR network sites and targeting community sites with diverse patient populations. This personalized outreach has resulted in several sites that initially declined participation, now joining the trial. The team has also collaborated across the organization to remove barriers to US enrollment targets, setting a goal of 20% of global enrollment from US sites, surpassing historical figures for recent Phase 3 studies. Heather and her team have fully leveraged available resources from AIR, HEPS, PDG, and others, building upon them to establish cross-functional best practices. Their efforts have demonstrated Genentech's commitment to inclusive research strategies and the strategic, patient, and commercial value they hold. Through their actions, they are not only making a meaningful impact on the healthcare landscape but also setting an example for the entire industry to follow.

Key D&I ContributorsStephanie Sassman, GPS D&I Team, Christina Matheny

Key D&I Contributors Nicole Richie, Rhona O’Leary, Global PD DEI team